MedTrace Logo

Tick-borne Encephalitis Virus Research in Limousin

NCT05941546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 878

Last updated 2026-04-08

No results posted yet for this study

Summary

Cases of encephalitis of varying severity have been described in recent years in eastern France involving tick-borne encephalitis virus (TBEV). The main objective is to demonstrate the presence of TBEV in Limousin, in patients with a positive Lyme serology, or a neurological picture compatible with TBEV.

Conditions

  • Tick-borne Encephalitis

Interventions

DIAGNOSTIC_TEST

anti-TBEV serology

we will measure by ELISA in microplates the anti-TBEV IgG as well as the anti-TBEV IgM on the sera + in TBEV IgG. We will then send a patient questionnaire with an information note to document the context of this TBEV seropositivity and to eliminate false-positivities (vaccination). Finally, we will perform PCR on CSF if serum positive and CSF available

Sponsors & Collaborators

  • University Hospital, Limoges

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2023-08-13
Completion
2023-08-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05941546 on ClinicalTrials.gov